Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HIV Infections drug therapy"" wg kryterium: Temat


Tytuł :
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
Autorzy :
Vasiliki Chounta
Sonya J. Snedecor
Sterling Wu
Nicolas Van de Velde
Pokaż więcej
Temat :
Anti-HIV agents/administration and dosage
Anti-retroviral agents/therapeutic use
HIV infections/drug therapy
Indirect treatment comparison
Long-acting
Infectious and parasitic diseases
RC109-216
Źródło :
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/1471-2334
Dostęp URL :
https://doaj.org/article/446be2387b564a26a79c5136e0905f74
Czasopismo naukowe
Tytuł :
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
Autorzy :
Chounta, VasilikiAff1, IDs12879022072433_cor1
Snedecor, Sonya J.
Wu, Sterling
Van de Velde, Nicolas
Pokaż więcej
Źródło :
BMC Infectious Diseases. 22(1)
Czasopismo naukowe
Tytuł :
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction—A Prospective Cohort Study
Autorzy :
Surial, Bernard
Béguelin, Charles
Chave, Jean-Philippe
Stöckle, Marcel
Boillat-Blanco, Noémie
Doco-Lecompte, Thanh
Bernasconi, Enos
Fehr, Jan
Günthard, Huldrych F
Schmid, Patrick
Walti, Laura N
Furrer, Hansjakob
Rauch, Andri
Wandeler, Gilles
Swiss HIV Cohort Study
Pokaż więcej
Temat :
Clinical Science
HIV/HBV coinfection
antiretroviral therapy outcomes
renal function
liver toxicity
tenofovir alafenamide
non-communicable diseases
Institute of Medical Virology
Epidemiology, Biostatistics and Prevention Institute (EBPI)
Clinic for Infectious Diseases
610 Medicine & health
Adenine/analogs & derivatives
Adenine/therapeutic use
Aged
Anti-HIV Agents/therapeutic use
Female
Glomerular Filtration Rate
HIV Infections/drug therapy
Hepatitis B/drug therapy
Hepatitis B virus
Humans
Interrupted Time Series Analysis
Kidney Diseases/chemically induced
Kidney Diseases/complications
Kidney Function Tests
Liver
Male
Middle Aged
Prospective Studies
Tenofovir/therapeutic use
Viral Load
Pharmacology (medical)
Infectious Diseases
Gastroenterology
medicine.medical_specialty
medicine
Proteinuria
medicine.symptom
Viral load
Coinfection
medicine.disease
Prospective cohort study
medicine.disease_cause
Internal medicine
Urine
business.industry
business
Renal function
Tenofovir alafenamide
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING
Źródło :
Journal of Acquired Immune Deficiency Syndromes (1999)
Surial, Bernard; Béguelin, Charles; Chave, Jean-Philippe; Stöckle, Marcel; Boillat-Blanco, Noémie; Doco-Lecompte, Thanh; Bernasconi, Enos; Fehr, Jan; Günthard, Huldrych F; Schmid, Patrick; Walti, Laura N; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles; Swiss HIV Cohort Study (2020). Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 85(2):227-232.
Journal of acquired immune deficiency syndromes, vol. 85, no. 2, pp. 227-232
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2994d50dcb69a3583b817f037786c8
http://europepmc.org/articles/PMC7495978
Tytuł :
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium
Autorzy :
Bastian Neesgaard
Amanda Mocroft
Robert Zangerle
Ferdinand Wit
Fiona Lampe
Huldrych F Günthard
Coca Necsoi
Matthew Law
Cristina Mussini
Antonella Castagna
Antonella d'Arminio Monforte
Christian Pradier
Nikoloz Chkhartisvilli
Juliana Reyes-Uruena
Jörg Janne Vehreschild
Jan-Christian Wasmuth
Anders Sönnerborg
Christoph Stephan
Lauren Greenberg
Josep M Llibre
Alain Volny-Anne
Lars Peters
Annegret Pelchen-Matthews
Vani Vannappagari
Joel Gallant
Armin Rieger
Mike Youle
Dominique Braun
Stephane De Wit
Kathy Petoumenos
Vanni Borghi
Vincenzo Spagnuolo
Tengiz Tsertsvadze
Jens Lundgren
Lene Ryom
RESPOND study group
Pokaż więcej
Temat :
Research Article
Biology and Life Sciences
Immunology
Vaccination and Immunization
Antiviral Therapy
Antiretroviral Therapy
Medicine and Health Sciences
Public and Occupational Health
Preventive Medicine
People and Places
Geographical Locations
Europe
Endocrinology
Endocrine Disorders
Diabetes Mellitus
Medical Conditions
Metabolic Disorders
Immune Response
Vascular Medicine
Blood Pressure
Hypertension
Nephrology
Renal Diseases
Chronic Kidney Disease
Cardiovascular Diseases
Cardiology
Cardiovascular Medicine
Pharmaceutics
Drug Therapy
Cardiovascular Therapy
Medicine
Science
Biologie
Sciences bio-médicales et agricoles
Psychologie appliquée
Multidisciplinary
Regimen
business.industry
business
Odds ratio
Cohort
Integrase inhibitor
Viral load
Internal medicine
medicine.medical_specialty
Population
education.field_of_study
education
Confidence interval
Reverse-transcriptase inhibitor
medicine.drug
Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)
General
Adult
CD4 Lymphocyte Count
Cohort Studies
Female
HIV/drug effects
HIV Infections/drug therapy
HIV Integrase Inhibitors/therapeutic use
HIV Protease Inhibitors/therapeutic use
Humans
Male
Middle Aged
Reverse Transcriptase Inhibitors/therapeutic use
Treatment Outcome
Viral Load/drug effects
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Biochemistry
Genetics and Molecular Biology(all)
Źródło :
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0243625 (2020)
PloS one, 15 (12 December
PLoS ONE, 15(12 December):e0243625. Public Library of Science
Neesgaard, B, Mocroft, A, Zangerle, R, Wit, F, Lampe, F, Günthard, H F, Necsoi, C, Law, M, Mussini, C, Castagna, A, Monforte, A DA, Pradier, C, Chkhartisvilli, N, Reyes-Uruena, J, Vehreschild, J J, Wasmuth, J-C, Sönnerborg, A, Stephan, C, Greenberg, L, Llibre, J M, Volny-Anne, A, Peters, L, Pelchen-Matthews, A, Vannappagari, V, Gallant, J, Rieger, A, Youle, M, Braun, D, De Wit, S, Petoumenos, K, Borghi, V, Spagnuolo, V, Tsertsvadze, T, Lundgren, J, Ryom, L & RESPOND Study Group 2020, ' Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting : The RESPOND cohort consortium ', PLoS ONE, vol. 15, no. 12, e0243625 . https://doi.org/10.1371/journal.pone.0243625
Opis pliku :
1 full-text file(s): application/pdf; application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b7e1131f1db9907055718899d452b1
http://europepmc.org/articles/PMC7774984
Tytuł :
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
Autorzy :
Bernard Surial
Matthias Cavassini
Alexandra Calmy
Jan Fehr
Marcel Stöckle
Enos Bernasconi
Bianca Roth
Christoph A. Fux
Helen Kovari
Hansjakob Furrer
Andri Rauch
Gilles Wandeler
the Swiss HIV Cohort Study
Pokaż więcej
Temat :
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Antiretroviral therapy
Switch
Toxicity
lcsh:Infectious and parasitic diseases
lcsh:RC109-216
Research Article
Adenine/analogs & derivatives
Adenine/therapeutic use
Adult
Anti-HIV Agents/therapeutic use
CD4 Lymphocyte Count
Cohort Studies
Drug Interactions
Female
HIV Infections/complications
HIV Infections/drug therapy
Hepatitis C, Chronic/complications
Hepatitis C, Chronic/pathology
Humans
Male
Middle Aged
Risk Factors
Switzerland
Tenofovir/adverse effects
Tenofovir/therapeutic use
Infectious Diseases
Cohort
Cohort study
Regimen
Medicine
business.industry
business
Logistic regression
Confidence interval
Reverse-transcriptase inhibitor
medicine.drug
Odds ratio
Internal medicine
medicine.medical_specialty
360 Social problems & social services
610 Medicine & health
Medical Clinic
Epidemiology, Biostatistics and Prevention Institute (EBPI)
Clinic for Infectious Diseases
Źródło :
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
BMC infectious diseases, vol. 19, no. 1, pp. 834
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles; Swiss HIV Cohort Study (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC Infectious Diseases, 19:834.
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9 <http://dx.doi.org/10.1186/s12879-019-4454-9>
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e4872fd47d082fd5c4208de5eb56dc
http://link.springer.com/article/10.1186/s12879-019-4454-9
Tytuł :
Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting
Autorzy :
Greenberg, Lauren
Ryom, Lene
Wandeler, Gilles
Grabmeier-Pfistershammer, Katharina
Öllinger, Angela
Neesgaard, Bastian
Stephan, Christoph
Calmy, Alexandra
Rauch, Andri
Castagna, Antonella
Spagnuolo, Vincenzo
Johnson, Margaret
Stingone, Christof
Mussini, Cristina
De Wit, Stéphane
Necsoi, Coca
Campins, Antoni A.
Pradier, Christian
Stecher, Melanie
Wasmuth, Jan-Christian
Monforte, Antonella dʼArminio
Law, Matthew
Puhr, Rainer
Chkhartishvilli, Nikoloz
Tsertsvadze, Tengiz
Garges, Harmony
Thorpe, David
Lundgren, Jens D.
Peters, Lars
Bansi-Matharu, Loveleen
Mocroft, Amanda
RESPOND Study Group
Pokaż więcej
Temat :
610 Medicine & health
Pharmacology (medical)
Infectious Diseases
Raltegravir
medicine.drug
medicine
business.industry
business
Integrase inhibitor
Proportional hazards model
Elvitegravir
Discontinuation
Dolutegravir
chemistry.chemical_compound
chemistry
Internal medicine
medicine.medical_specialty
Coinfection
medicine.disease
Hepatitis C
ddc:616
Adult
Anti-HIV Agents/administration & dosage
Anti-HIV Agents/adverse effects
Anti-HIV Agents/therapeutic use
Cohort Studies
Europe
Female
HIV Infections/drug therapy
Humans
Integrase Inhibitors/administration & dosage
Integrase Inhibitors/adverse effects
Integrase Inhibitors/therapeutic use
Male
Middle Aged
animal structures
Źródło :
Greenberg, Lauren; Ryom, Lene; Wandeler, Gilles; Grabmeier-Pfistershammer, Katharina; Öllinger, Angela; Neesgaard, Bastian; Stephan, Christoph; Calmy, Alexandra; Rauch, Andri; Castagna, Antonella; Spagnuolo, Vincenzo; Johnson, Margaret; Stingone, Christof; Mussini, Cristina; De Wit, Stéphane; Necsoi, Coca; Campins, Antoni A; Pradier, Christian; Stecher, Melanie; Wasmuth, Jan-Christian; ... (2020). Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting. Journal of acquired immune deficiency syndromes JAIDS, 83(3), pp. 240-250. Wolters Kluwer Health 10.1097/QAI.0000000000002250 <http://dx.doi.org/10.1097/QAI.0000000000002250>
Journal of Acquired Immune Deficiency Syndromes, Vol. 83, No 3 (2020) pp. 240-250
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57720ea1f0f49399c3e213c548f4eed
https://boris.unibe.ch/139181/1/Uptake_and_discontinuation_of_integrase_inhibitors.96259 (1).pdf
Tytuł :
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations
Autorzy :
Nikoloz Chkhartishvili
Eric Florence
Roxana Radoi
Brigitte Schmied
Josip Begovac
Brygida Knysz
Dzmitry Paduta
Patrick Schmid
Elena Kuzovatova
Leah Shepherd
Gerd Fätkenheuer
Amanda Mocroft
Jens D. Lundgren
Pere Domingo
Jelena Smidt
Janos Szlavik
Dalibor Sedláček
Ole Kirk
Fiona Mulcahy
Kamilla Laut
Matti Ristola
Magnus Gottfredsson
Pokaż więcej
Temat :
Infectious Diseases
Immunology
Immunology and Allergy
Odds ratio
Viral load
Public health
medicine.medical_specialty
medicine
Cohort
Logistic regression
Transmission (mechanics)
law.invention
law
Demography
Cohort study
Confidence interval
Adult
Anti-Retroviral Agents/therapeutic use
Antiretroviral Therapy, Highly Active/methods
Cohort Studies
Drug Utilization/statistics & numerical data
Europe
Female
Geography
HIV Infections/drug therapy
Humans
Male
Middle Aged
Population Groups
Sexual Behavior
Sustained Virologic Response
Treatment Outcome
Viral Load
Źródło :
Laut, K G, Shepherd, L, Gottfredsson, M, Sedlacek, D, Knysz, B, Begovac, J, Radoi, R, Schmied, B, Chkhartishvili, N, Florence, E, Ristola, M, Fätkenheuer, G, Mulcahy, F, Schmid, P, Kuzovatova, E, Paduta, D, Smidt, J, Domingo, P, Szlávik, J, Lundgren, J, Mocroft, A, Kirk, O & EuroSIDA Study Group 2018, ' Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations ', AIDS (London, England), vol. 32, no. 18, pp. 2807-2819 . https://doi.org/10.1097/QAD.0000000000002035
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fe07dda086d59b27922bbc33c005c7
https://journals.lww.com/10.1097/QAD.0000000000002035
Tytuł :
Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy
Autorzy :
Lelubre, Mélanie
Clerc, Olivier
Grosjean, Marielle
Amighi, Karim
De Vriese, Carine
Bugnon, Olivier
Schneider, Marie-Paule
Pokaż więcej
Temat :
Implementation process
Implementation strategies
FISpH
Medication adherence
IMAP
Community pharmacy service
lcsh:Public aspects of medicine
lcsh:RA1-1270
Sciences pharmaceutiques
HIV patients
Interprofessionality
Health Policy
Health administration
Medical education
Pharmacy
business.industry
business
Public hospital
Stakeholder
Medicine
Public health
medicine.medical_specialty
Health informatics
Nursing research
Ambulatory care
Ambulatory Care/organization & administration
Community Pharmacy Services/organization & administration
HIV Infections/drug therapy
Health Personnel
Health Resources/statistics & numerical data
Hospitals/statistics & numerical data
Humans
Interprofessional Relations
Medication Adherence
Medication Therapy Management/organization & administration
Pharmacies/organization & administration
Pharmacists/organization & administration
Switzerland
Research Article
Źródło :
BMC Health Services Research, Vol 18, Iss 1, Pp 1-8 (2018)
BMC health services research, 18
BMC health services research, vol. 18, no. 1, pp. 698
BMC Health Services Research
Opis pliku :
2 full-text file(s): application/pdf; application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbebf183880e2fccd4d0b042145cfdb
http://link.springer.com/article/10.1186/s12913-018-3509-8
Tytuł :
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection
Autorzy :
Isabelle Poizot-Martin
David Rey
Rémonie Seng
Jacques Reynes
Antoine Cheret
Laurent Cotte
Caroline Lascoux Combe
Clotilde Allavena
Raphael Veil
Laure Surgers
Cécile Goujard
Laurence Meyer
Pierre Delobel
Claudine Duvivier
Laurent Tran
Pokaż więcej
Temat :
CD4þlymphocyte count
CD4þ–CD8þratio
integrase inhibitors
primary HIV infection
viral load
MESH: Adult
MESH: CD4 Lymphocyte Count
MESH: Viral Load
MESH: CD4-CD8 Ratio
MESH: Cohort Studies Darunavir / therapeutic use
MESH: Female
MESH: HIV Infections / drug therapy
MESH: HIV Infections / immunology
MESH: HIV Integrase Inhibitors / therapeutic use
MESH: HIV Protease Inhibitors / therapeutic use
MESH: Heterocyclic Compounds, 3-Ring / therapeutic use
MESH: Humans
MESH: Logistic Models
MESH: Male
MESH: Middle Aged
MESH: Oxazines / therapeutic use
MESH: Piperazines / therapeutic use
MESH: Pyridones / therapeutic use
MESH: Sustained Virologic Response
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Infectious Diseases
Immunology
Immunology and Allergy
Human immunodeficiency virus (HIV)
medicine.disease_cause
medicine
Antiretroviral therapy
CD8
Gastroenterology
medicine.medical_specialty
business.industry
business
Cart
Integrase inhibitor
Darunavir
medicine.drug
Dolutegravir
chemistry.chemical_compound
chemistry
Internal medicine
Cohort
Źródło :
AIDS
AIDS, Lippincott, Williams & Wilkins, 2020, 34 (4), pp.493-500. ⟨10.1097/QAD.0000000000002447⟩
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4884625e388980901de465e7b1235fbe
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03232130
Tytuł :
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa:modelling to inform treatment guidelines
Autorzy :
Ruanne V. Barnabas
Elliot Raizes
Alexandra Calmy
John W. Mellors
George K. Siberry
Deenan Pillay
Nathan Ford
Jens D. Lundgren
Francois Venter
Owen Mugurungi
Annemarie M J Wensing
Valentina Cambiano
David Ripin
Paul Revill
Silvia Bertagnolio
Anton Pozniak
Loveleen Bansi-Matharu
Tsitsi Apollo
Daniel R. Kuritzkes
Ravindra K. Gupta
Jennifer Cohn
Andreas Jahn
Diane V. Havlir
Andrew N. Phillips
Juliana Da Silva
Pokaż więcej
Temat :
Adolescent
Adult
Africa South of the Sahara
Alkynes
Anti-HIV Agents/administration & dosage
Benzoxazines/administration & dosage
Cost-Benefit Analysis
Cyclopropanes
Female
HIV Infections/drug therapy
Heterocyclic Compounds, 3-Ring/administration & dosage
Humans
Infectious Disease Transmission, Vertical/prevention & control
Male
Middle Aged
Oxazines
Piperazines
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications/drug therapy
Pyridones
Randomized Controlled Trials as Topic
Young Adult
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Article
HIV Infections
Pregnancy Complications
Benzoxazines
Heterocyclic Compounds, 3-Ring
Anti-HIV Agents
Infectious Disease Transmission, Vertical
Virology
Infectious Diseases
Immunology
Epidemiology
Population health
Demography
Regimen
Tolerability
medicine.disease
medicine
Dolutegravir
chemistry.chemical_compound
chemistry
Cost–benefit analysis
Efavirenz
business.industry
business
Population
education.field_of_study
education
ddc:616
Anti-HIV Agents/economics
Benzoxazines/economics
HIV Infections/economics
HIV Infections/transmission
Heterocyclic Compounds, 3-Ring/economics
Pregnancy Complications/virology
Źródło :
Phillips, A N, Bansi-Matharu, L, Venter, F, Havlir, D, Pozniak, A, Kuritzkes, D R, Wensing, A, Lundgren, J D, Pillay, D, Mellors, J, Cambiano, V, Jahn, A, Apollo, T, Mugurungi, O, Ripin, D, Da Silva, J, Raizes, E, Ford, N, Siberry, G K, Gupta, R K, Barnabas, R, Revill, P, Cohn, J, Calmy, A & Bertagnolio, S 2020, ' Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa : modelling to inform treatment guidelines ', The Lancet HIV, vol. 7, no. 3, pp. e193-e200 . https://doi.org/10.1016/S2352-3018(19)30400-X
The Lancet. HIV
The Lancet HIV, Vol. 7, No 3 (2020) pp. e193-e200
Opis pliku :
application/pdf; Print-Electronic
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc92a4b1f277e8a737e130ba54367a1
https://curis.ku.dk/portal/da/publications/updated-assessment-of-risks-and-benefits-of-dolutegravir-versus-efavirenz-in-new-antiretroviral-treatment-initiators-in-subsaharan-africa(9601ba46-7db6-4540-80fd-6a56529a43c7).html
Tytuł :
HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection
Autorzy :
Sara Gianella
Gemma Caballero
Christophe Vanpouille
Milenka V. Vargas
Andrea Lisco
Antoine Chaillon
Davey M. Smith
Parris Jordan
Sanjay Mehta
Pokaż więcej
Temat :
Pharmacology (medical)
Infectious Diseases
Blood plasma
Virus
Inflammation
medicine.symptom
medicine
Virology
Population
education.field_of_study
education
Peripheral blood mononuclear cell
Sex organ
Semen
Men who have sex with men
Biology
Blood
Humans
Herpesviridae
HIV
HIV Infections
Cytokines
Anti-HIV Agents
Viral Load
Longitudinal Studies
Sequence Analysis
DNA
Homosexuality
Male
Phylogeny
Genotype
env Gene Products
Human Immunodeficiency Virus
Secondary Prevention
Bayesian inference
phylogeography
compartmentalization
Markov
seminal plasma
PBMC
Clinical Research
HIV/AIDS
Infection
Anti-HIV Agents/*administration & dosage Blood/*virology Cytokines/blood Genotype HIV/classification/genetics/*isolation & purification HIV Infections/*drug therapy/*virology Herpesviridae/isolation & purification Homosexuality
Male Humans Longitudinal Studies Male Phylogeny *Secondary Prevention Semen/*virology Sequence Analysis
DNA Viral Load env Gene Products
Human Immunodeficiency Virus/genetics
Clinical Sciences
Public Health and Health Services
Article
Sequence Analysis, DNA
Homosexuality, Male
env Gene Products, Human Immunodeficiency Virus
Anti-HIV Agents/*administration & dosage Blood/*virology Cytokines/blood Genotype HIV/classification/genetics/*isolation & purification HIV Infections/*drug therapy/*virology Herpesviridae/isolation & purification Homosexuality, Male Humans Longitudinal Studies Male Phylogeny *Secondary Prevention Semen/*virology Sequence Analysis, DNA Viral Load env Gene Products, Human Immunodeficiency Virus/genetics
Źródło :
Journal of acquired immune deficiency syndromes (1999), vol 74, iss 1
Chaillon, Antoine; Smith, Davey M; Vanpouille, Christophe; Lisco, Andrea; Jordan, Parris; Caballero, Gemma; et al.(2017). HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection.. Journal of acquired immune deficiency syndromes (1999), 74(1), 95-102. doi: 10.1097/QAI.0000000000001156. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/59g5j63f
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77560aefec1d5c35b503c23bf6a76160
https://journals.lww.com/10.1097/QAI.0000000000001156
Tytuł :
Mortality from suicide among people living with HIV and the general Swiss population: 1988‐2017
Autorzy :
Ruffieux, Yann
Lemsalu, Liis
Aebi‐Popp, Karoline
Calmy, Alexandra
Cavassini, Matthias
Fux, Christoph A
Günthard, Huldrych F
Marzolini, Catia
Scherrer, Alexandra
Vernazza, Pietro
Keiser, Olivia
Egger, Matthias
Anagnostopoulos, A
Battegay, M
Bernasconi, E
Böni, J
Braun, DL
Bucher, HC
Ciuffi, A
Dollenmaier, G
Elzi, L
Fehr, J
Fellay, J
Furrer, H
Haerry, D
Hasse, B
Hirsch, HH
Hoffmann, M
Hösli, I
Huber, M
Kahlert, CR
Kaiser, L
Klimkait, T
Kouyos, RD
Kovari, H
Ledergerber, B
Martinetti, G
Martinez de Tejada, B
Metzner, KJ
Müller, N
Nicca, D
Paioni, P
Pantaleo, G
Perreau, M
Rauch, A
Rudin, C
Schmid, P
Speck, R
Stöckle, M
Tarr, P
Trkola, A
Wandeler, G
Weber, R
Yerly, S TBD
the Swiss HIV Cohort Study and the Swiss National Cohort
Pokaż więcej
Temat :
Infectious Diseases
Public Health, Environmental and Occupational Health
Poison control
Mortality rate
Medicine
business.industry
business
Injury prevention
Demography
Suicide prevention
Hazard ratio
Population
education.field_of_study
education
Cohort study
Proportional hazards model
Short Report
Short Reports
HIV
suicide
Switzerland
SMR
comparative study
intravenous drug use
ddc:616
ddc:613
Suicide
Comparative study
Intravenous drug use
Institute of Medical Virology
Medical Clinic
Clinic for Infectious Diseases
610 Medicine & health
360 Social problems & social services
Adult
Anti-Retroviral Agents/therapeutic use
Antiretroviral Therapy, Highly Active/methods
Cohort Studies
Female
HIV Infections/drug therapy
HIV Infections/mortality
Humans
Male
Middle Aged
Risk Factors
Suicide/statistics & numerical data
Switzerland/epidemiology
Źródło :
Journal of the International AIDS Society
Journal of the International AIDS society, Vol. 22, No 8 (2019) P. e25339
Ruffieux, Yann; Lemsalu, Liis; Aebi-Popp, Karoline; Calmy, Alexandra; Cavassini, Matthias; Fux, Christoph A; Günthard, Huldrych F; Marzolini, Catia; Scherrer, Alexandra; Vernazza, Pietro; Keiser, Olivia; Egger, Matthias; Swiss HIV Cohort Study; Swiss National Cohort Study Group (2019). Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. Journal of the International Aids Society, 22(8):e25339.
Ruffieux, Yann; Lemsalu, Liis; Aebi-Popp, Karoline; Calmy, Alexandra; Cavassini, Matthias; Fux, Christoph A; Günthard, Huldrych F; Marzolini, Catia; Scherrer, Alexandra; Vernazza, Pietro; Keiser, Olivia; Egger, Matthias (2019). Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. Journal of the International AIDS Society, 22(8), e25339. BioMed Central 10.1002/jia2.25339 <http://dx.doi.org/10.1002/jia2.25339>
Journal of the International AIDS Society, vol. 22, no. 8, pp. e25339
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef4a969ce984f8e4eb491faee4e5cc3c
Tytuł :
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement
Autorzy :
Banga, Riddhima
Rebecchini, Caterina
Procopio, Francesco Andrea
Noto, Alessandra
Munoz, Olivia
Ioannidou, Kalliopi
Fenwick, Craig
Ohmiti, Khalid
Cavassini, Matthias
Corpataux, Jean-Marc
de Leval, Laurence
Pantaleo, Giuseppe
Perreau, Matthieu
Pokaż więcej
Temat :
Virology
Genetics
Molecular Biology
Immunology
Microbiology
Parasitology
CD155
biology.protein
biology
Lymph node
medicine.anatomical_structure
medicine
Germinal center
TIGIT
Interleukin-7 receptor
Cell
Transcription (biology)
Immune checkpoint
Cell biology
Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Research Article
Biology and Life Sciences
Medical Microbiology
Microbial Pathogens
Viral Pathogens
Immunodeficiency Viruses
HIV
HIV-1
Medicine and Health Sciences
Pathology and Laboratory Medicine
Pathogens
Organisms
Viruses
RNA viruses
Retroviruses
Lentivirus
Cell Biology
Cellular Types
Animal Cells
Blood Cells
White Blood Cells
T Helper Cells
Immune Cells
T cells
Memory T cells
Anatomy
Body Fluids
Blood
Physiology
Lymphatic System
Lymph Nodes
Viral Replication
Anti-HIV Agents/therapeutic use
Antibodies, Monoclonal, Humanized/administration & dosage
Cell Movement/immunology
Cellular Microenvironment/immunology
Coculture Techniques
Dendritic Cells/immunology
Dendritic Cells/virology
Germinal Center/immunology
Germinal Center/virology
HIV Infections/drug therapy
HIV Infections/immunology
HIV Infections/virology
HIV-1/genetics
HIV-1/immunology
HIV-1/pathogenicity
Host Microbial Interactions/immunology
Humans
In Vitro Techniques
Lymph Nodes/immunology
Lymph Nodes/virology
Programmed Cell Death 1 Ligand 2 Protein/metabolism
Programmed Cell Death 1 Receptor/antagonists & inhibitors
Programmed Cell Death 1 Receptor/metabolism
Receptors, Immunologic/metabolism
Receptors, Virus/metabolism
T-Lymphocytes, Helper-Inducer/immunology
T-Lymphocytes, Helper-Inducer/virology
Transcription, Genetic
Virulence
Źródło :
PLoS Pathogens, Vol 15, Iss 7, p e1007918 (2019)
PLoS Pathogens
PLoS pathogens, vol. 15, no. 7, pp. e1007918
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a75d9b74797de056653603fd5facae8
Tytuł :
Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc
Autorzy :
Susan J. Little
Antoine Chaillon
Josué Pérez-Santiago
Sanjay Mehta
Sara Gianella
Steven M. Lada
Joel O. Wertheim
Caroline C. Ignacio
Douglas D. Richman
Davey M. Smith
Parris Jordan
Maile Y. Karris
Pokaż więcej
Temat :
Genetic Diversity and Evolution
Virology
Insect Science
Immunology
Microbiology
Viral evolution
Interquartile range
Maraviroc
chemistry.chemical_compound
chemistry
Viremia
medicine.disease
medicine
Biology
Viral replication
Entry inhibitor
medicine.drug
Deep sequencing
Viral load
Humans
HIV-1
HIV Infections
Cyclohexanes
Triazoles
DNA, Viral
RNA, Viral
Antiretroviral Therapy, Highly Active
Viral Load
Bayes Theorem
Double-Blind Method
Virus Replication
Adult
California
Female
Male
Young Adult
CCR5 Receptor Antagonists
ART intensification
HIV
evolution
reservoir
Adult Antiretroviral Therapy, Highly Active Bayes Theorem CCR5 Receptor Antagonists/*therapeutic use California Cyclohexanes/*therapeutic use DNA, Viral/blood Double-Blind Method Female HIV Infections/*drug therapy/virology HIV-1/genetics/physiology Humans Male Maraviroc RNA, Viral/blood Triazoles/*therapeutic use Viral Load Viremia/*drug therapy Virus Replication/*drug effects Young Adult *ART intensification *Hiv *evolution *maraviroc *reservoir
Biological Sciences
Agricultural and Veterinary Sciences
Medical and Health Sciences
DNA
Viral
RNA
Antiretroviral Therapy
Highly Active
Clinical Research
Infectious Diseases
Clinical Trials and Supportive Activities
HIV/AIDS
6.1 Pharmaceuticals
Infection
Adult Antiretroviral Therapy
Highly Active Bayes Theorem CCR5 Receptor Antagonists/*therapeutic use California Cyclohexanes/*therapeutic use DNA
Viral/blood Double-Blind Method Female HIV Infections/*drug therapy/virology HIV-1/genetics/physiology Humans Male Maraviroc RNA
Viral/blood Triazoles/*therapeutic use Viral Load Viremia/*drug therapy Virus Replication/*drug effects Young Adult *ART intensification *Hiv *evolution *maraviroc *reservoir
Źródło :
Chaillon, Antoine; Gianella, Sara; Lada, Steven M; Perez-Santiago, Josué; Jordan, Parris; Ignacio, Caroline; et al.(2018). Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.. Journal of virology, 92(3). doi: 10.1128/JVI.01589-17. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2dz5q4q8
Journal of virology, vol 92, iss 3
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5db9c6ca94addc5ddb77c1d14d6fc0
https://europepmc.org/articles/PMC5774877/

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies